Trade Amgen AMGN

Sell
 Buy

Amgen live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close change Change (%) Open High Low

Amgen news

Frances Wang 2024 Nov 26, 16:00

Stock Market Today: S&P 500 and Dow Reach New High On Trump’s Tariff Policy

Stocks
Frances Wang 2024 Aug 04, 16:00

The Week Ahead: ISM services, SMCI

CFD Trading
Australian dollar shrugs at RBA decision to keep interest rates unchanged
Georgy Istigechev 2024 Aug 03, 21:00

Week ahead: RBA meeting, Uber earnings, and PMIs

CFD Trading Forex
Disney is catching up with Netflix
Neil Wilson 2024 Feb 01, 08:03

Week ahead: Earnings season climax

Forex Indices
Bank of England BoE
Neil Wilson 2023 Oct 27, 10:00

Week ahead: Fed, Bank of England seen on pause; Apple earnings

Forex Indices

Latest news

Show more
Tommy Yap 2025 Jun 21, 21:00

Week Ahead: Fed Inflation Gauge: Core PCE Price Index in the Spotlight

Forex Indices
Tommy Yap 2025 Jun 19, 16:00

Morning Note: Dollar Climbs on Mideast Tensions; Oil Dips; Accenture Q3

Morning Note USD Indices Commodities
Frances Wang 2025 Jun 18, 16:00

BTCUSD Analysis: Bitcoin Price Dropped Amid Iran-Israel Tensions

Cryptocurrencies
Tommy Yap 2025 Jun 18, 16:00

Morning Note: Stablecoin Boom on Senate Bill; SNB and BoE Rate Decisions Awaited

Morning Note Cryptocurrencies Forex
Frances Wang 2025 Jun 17, 16:00

Stock News Today: European Stocks Fall, Germany's DAX Index Dips

Stocks
Frances Wang 2025 Jun 17, 16:00

Stock market bounce back: Dow, S&P 500, and Nasdaq rebound

Stocks
Tommy Yap 2025 Jun 17, 16:00

Morning Note: Gold's Retreat; Fed's Steady Hand; UK CPI Outlook

Morning Note Commodities
Darius Anucauskas 2025 Jun 17, 16:00

Morning Note: Fed in Focus, EU Inflation, Nasdaq & DAX

Morning Note Stocks

Info

Spread

1.84

Spread (%)

0.6379 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Monday

13:31 - 19:59

Tuesday

13:31-19:59

Wednesday

13:31-19:59

Friday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

155574468608

Shares Outstanding

537705984

Earnings Date (Next)

1999-11-22

instr__dividend_date

2025-06-06

instr__ex_dividend_date

2025-05-16

instr__forward_annual_dividend_rate

9.52

instr__forward_annual_dividend_yield

0.0329

EPS

10.97

Learn more about this instrument

Amgen Amgen Inc
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for men and women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including Neulasta, MVASI, AMJEVITA/AMGEVITA, TEZSPIRE, Parsabiv, Aimovig, LUMAKRAS/LUMYKRAS, EPOGEN, KANJINTI, TAVNEOS, RAVICTI, UPLIZNA and PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; Novartis Pharma AG to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
View all instruments

Latest Education Articles

Show more
Trustpilot